Skip to main content
Frontiers in Aging Neuroscience logoLink to Frontiers in Aging Neuroscience
. 2023 Aug 2;15:1250440. doi: 10.3389/fnagi.2023.1250440

Corrigendum: CREB5 hypermethylation involved in the ganglioside GM1 therapy of Parkinson's disease

Rui Wang 1,, Shanshan Tong 1,, Mengdi Wang 1, Junjie Zou 2, Nan Wang 3, Fengjiao Sun 3, Xiaosheng Zhou 1,*, Jinbo Chen 1, Hongcai Wang 1,*
PMCID: PMC10434278  PMID: 37600516

In the published article, there was an error in Figure 5A, Image d as published. We inadvertently used the wrong figure and need to correct the Figure 5A, Image d. The other elements of the Figure 5 remain the same. The corrected Figure 5A, Image d and its caption appear below.

Figure 5.

Figure 5

GM1 prevented ROT-induced cell apoptosis. (A, B) Impaired neurite outgrowth was inhibited by GM1 addition. Scale bar = 10 μm. (C, D) GM1 decreased ROT-induced cell apoptosis. *P < 0.05; ****P < 0.0001; #,##P > 0.05.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Aging Neuroscience are provided here courtesy of Frontiers Media SA

RESOURCES